Company intelligence / Profile preview

SaluMedica

Atlanta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

SaluMedica developed implantable medical devices based on its Salubria hydrogel to address cartilage and soft-tissue-related orthopedic conditions, aiming to fill the gap between conservative care and major joint surgery; at least some products progressed to regulatory review and commercial use, but detailed recent clinical data are not publicly prominent.

Therapeutic areas: Rheumatology
Modalities: DeviceHydrogel-based drug delivery therapy
Industry: Implantable Medical Devices

Partnerships

MiMedx Group

Beyond the preview

Go deeper on SaluMedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SaluMedica.

Explore the full profile